Why plasma-derived factor VIII?
Haemophilia
.
2019 May;25(3):e183-e185.
doi: 10.1111/hae.13705.
Epub 2019 Mar 13.
Authors
Louis Aledort
1
,
Shannon L Carpenter
2
,
Adam Cuker
3
,
Roshni Kulkarni
4
,
Michael Recht
5
,
Guy Young
6
,
Cindy Leissinger
7
Affiliations
1
Department of Hematology-Oncology, Icahn School of Medicine, New York, New York.
2
Children's Mercy Hospital, Kansas City, Missouri.
3
University of Pennsylvania, Philadelphia, Pennsylvania.
4
Michigan State University, East Lansing, Michigan.
5
Oregon Health and Science University Hospital, Portland, Oregon.
6
University of Southern California, Los Angeles, California.
7
Tulane University, New Orleans, Louisiana.
PMID:
30866124
DOI:
10.1111/hae.13705
No abstract available
Publication types
Letter
MeSH terms
Factor VIII / metabolism*
Factor VIII / therapeutic use*
Humans
Plasma / metabolism*
Substances
Factor VIII